ArticleVision (Basel, Switzerland)2026

Adverse Events Reported with Standard-Dose and High-Dose Aflibercept: A FAERS Pharmacovigilance Study.

Minali Prasad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.